Biology of the multidrug resistance-associated protein, MRP
- 30 June 1996
- journal article
- review article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 32 (6), 945-957
- https://doi.org/10.1016/0959-8049(96)00046-9
Abstract
No abstract availableThis publication has 82 references indexed in Scilit:
- ATP‐dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletionFEBS Letters, 1995
- The Leukotriene LTD4 Receptor Antagonist Mk571 Specifically Modulates MRP Associated Multidrug ResistanceBiochemical and Biophysical Research Communications, 1995
- Mechanisms of MRP over‐expression in four human lung‐cancer cell lines and analysis of the MRP ampliconInternational Journal of Cancer, 1995
- Phosphorylation of the Multidrug Resistance Encoded Protein P190Biochemistry, 1995
- The Specific Bisindolylmaleimide PKC-Inhibitor GF 109203X Efficiently Modulates MRP-Associated Multiple Drug ResistanceBiochemical and Biophysical Research Communications, 1995
- A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypesEuropean Journal of Cancer, 1994
- Characterization of the ATP‐dependent leukotriene C4 export carrier in mastocytoma cellsJBIC Journal of Biological Inorganic Chemistry, 1994
- Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoproteinEuropean Journal of Cancer, 1993
- Modulation by d,l-buthionine-S,R-sulphoximine of etoposide cytotoxicity on human non-small cell lung, ovarian and breast carcinoma cell linesEuropean Journal of Cancer, 1992
- The products of the mdrla and mdrlb genes from multidrug resistant murine cells have similar degradation ratesLife Sciences, 1990